HCV type 2a Nucleocapsid, recombinant protein from E. coli
Recombinant Hepatitic C Virus Nucleocapsid genotype 2a
Immunoreactive with sera of HCV-infected individuals.
Protein is > 95% pure as determined by 10% PAGE (coomassie staining).
1mg/ml, in 50 mM Tris. pH 8.0 and 5 mM EDTA.
2-8°C short term, -20°C long term
Hepatitis C is a contagious liver disease that results from infection with the hepatitis C virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. The hepatitis C virus is usually spread when blood from an infected person enters the body of a susceptible person. It is among the most common viruses that infect the liver.
HCV Nucelocapsid; Hepatitis C Virus Nucelocapsid; Hepatitis C Virus; HCV; Hep C; Hepatitis C Virus Core; Hepatitis C Virus (Core); Hepatitis C; HCV Nucleocapsid (Core) protein (22 kDa); Hepatitis C Virus Nucleocapsid (Core) protein (22 kDa)